The dynamic relationship between elafin and elastase and the observation that elafin is mainly expressed in normal cells and not detectable in tumor cells (Figure 4A) led us to hypothesize that breast cancer cells expressing elafin have decreased tumorigenic potential, similar to that observed in breast cancer cells with elastase inhibited by shRNA (Figures 1, 2, 3). Here, PI3 is linked to neoplasm.